Udskriv Udskriv
Switch language
Hvidovre Hospital - en del af Københavns Universitetshospital

Efficacy of Endoscopic Dilation of gastroduodenal Crohn's disease strictures: A Systematic Review and Meta-analysis of Individual Patient Data

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review


  1. Reply

    Publikation: Bidrag til tidsskriftLetterpeer review

  2. Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Dominik Bettenworth
  • Marcus M Mücke
  • Rocio Lopez
  • Amandeep Singh
  • Weiming Zhu
  • Feilong Guo
  • Toshiyuki Matsui
  • Theodore W James
  • Hans Herfarth
  • Martin Goetz
  • Ren Mao
  • Satya Kurada
  • Jochen Hampe
  • Katja Matthes
  • John Gásdal Karstensen
  • Piero V Valli
  • Marjolijn Duijvestein
  • Geert D'Haens
  • Vipul Jairath
  • Tian Bai Qiu
  • Nik Sheng Ding
  • Gerhard Rogler
  • Florian Rieder
Vis graf over relationer

BACKGROUND & AIMS: Little is known about the effects of endoscopic balloon dilation (EBD) for strictures of the upper gastrointestinal (UGI) tract in patients with Crohn's disease (CD). We performed a pooled analysis of the efficacy and safety of EBD for UGI CD-associated strictures.

METHODS: We searched Embase, Medline, and the Cochrane library, as well as bibliographies of relevant articles, for cohort studies of adults with CD and strictures of the stomach or duodenum (up to the ligament of Treitz) who underwent EBD through December 2016. We obtained data from 7 international referral centers on 94 patients who underwent 141 EBDs. We performed a patient-level meta-analysis of data from published and unpublished cohort studies to determine mechanical and clinical success. We performed a time-to-event analysis to assess symptom recurrence and need for redilation or surgery. The patients analyzed had strictures of the duodenum (n = 107), stomach (n = 30), or spanning both (n = 4).

RESULTS: The rate of technical success for EBD was 100%, with 87% short-term clinical efficacy; major complications arose from 2.9% of all procedures. During a median follow-up period of 23.1 months, 70.5% of patients had a recurrence of symptoms, 59.6% required redilation, and 30.8% required surgical intervention. Patients whose disease was located in the small bowel had a higher risk for symptom recurrence (hazard ratio [HR], 2.1; P = .003). Asian race (HR, 2.8; P < .001) and location of disease in the small bowel (HR, 1.9; P = .004) increased the need for redilation. Prestenotic dilation was a risk factor for needing surgery earlier (HR, 1.9; P = .001).

CONCLUSIONS: In a meta-analysis, we found EBD for CD-associated strictures of the UGI to be an effective alternative to surgery, with a high rate of short-term technical and clinical success, moderate long-term efficacy, and an acceptable rate of complications.

TidsskriftClinical Gastroenterology and Hepatology
Udgave nummer12
Sider (fra-til)2514-2522.e8
Antal sider9
StatusUdgivet - nov. 2019

ID: 55820761